Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Alto Neuroscience Inc. (NYSE: ANRO) closed the day trading at $10.78 down -21.49% from the previous closing price of $13.73. In other words, the price has decreased by -$21.49 from its previous closing price. On the day, 1.21 million shares were traded. ANRO stock price reached its highest trading level at $12.85 during the session, while it also had its lowest trading level at $10.5.
Ratios:
For a better understanding of ANRO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.02 and its Current Ratio is at 26.02. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On February 27, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $32.Stifel initiated its Buy rating on February 27, 2024, with a $32 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 10 ’24 when Savitz Adam bought 2,931 shares for $13.22 per share. The transaction valued at 38,748 led to the insider holds 39,851 shares of the business.
Savitz Adam bought 12,069 shares of ANRO for $152,085 on Jul 09 ’24. The CHIEF MEDICAL OFFICER now owns 36,920 shares after completing the transaction at $12.60 per share. On Mar 28 ’24, another insider, Smith Nicholas Conrad, who serves as the CHIEF FINANCIAL OFFICER of the company, bought 6,150 shares for $16.36 each. As a result, the insider paid 100,628 and bolstered with 26,866 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANRO now has a Market Capitalization of 289809504 and an Enterprise Value of 173119440.
Stock Price History:
Over the past 52 weeks, ANRO has reached a high of $24.00, while it has fallen to a 52-week low of $9.40. The 50-Day Moving Average of the stock is -13.87%, while the 200-Day Moving Average is calculated to be -22.85%.
Shares Statistics:
Over the past 3-months, ANRO traded about 128.83K shares per day on average, while over the past 10 days, ANRO traded about 208810 shares per day. A total of 26.88M shares are outstanding, with a floating share count of 22.10M. Insiders hold about 17.79% of the company’s shares, while institutions hold 60.41% stake in the company. Shares short for ANRO as of 1721001600 were 3415269 with a Short Ratio of 26.51, compared to 1718323200 on 2878720. Therefore, it implies a Short% of Shares Outstanding of 3415269 and a Short% of Float of 16.139999.
